TickerFacts.

Biomolecular Life Holdings, Inc. (BIOM): R&D Expense

Annual figures by period end, from SEC filings.

Not updated since 2014-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

$865.7K
Year ended 2014-12-31
2013-12-31: $808.5K2014-12-31: $865.7K$865.7K
2013-12-31 R&D Expense (USD) 2014-12-31
Period endedR&D ExpenseChange YoYSource filing
2014-12-31$865.7K+7.1%2015-04-15, From 2014-01-01
2013-12-31$808.5Kn/a2015-04-15, From 2013-01-01